Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Status:
Recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
It is a prospective and multi-center clinical research in China to compare the efficacy,
safety and related impact factors between TACE alone and endovascular brachytherapy combined
with stent placement and TACE for HCC with main portal vein tumor thrombus.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborators:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences Changhai Hospital Changzhou Wujin People's Hospital First Affiliated Hospital of Zhejiang University First Hospital of China Medical University Fujian Medical University Union Hospital Fujian Provincial Hospital Harbin Medical University Hunan Cancer Hospital LanZhou University Lishui Country People's Hospital RenJi Hospital Ruijin Hospital Second Affiliated Hospital, School of Medicine, Zhejiang University Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Tengzhou Central People's Hospital The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Shanxi Medical University The First Affiliated Hospital of Soochow University The First Affiliated Hospital of Zhengzhou University The First Affiliated Hospital with Nanjing Medical University The First Hospital of Lanzhou University The Second People's Hospital of Yibin Wuhan Union Hospital, China Yancheng Third People's Hospital Zhejiang University Zhongshan Hospital Xiamen University ZhuHai Hospital